MktsMarkets

Inovio Pharmaceuticals, Inc.
NASDAQ: INOKey statistics
INO News
Stories mentioning INO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 65.00 | 117.00 | 0.00 | 101.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 14,070 | 10,262 | 13,333 | 14,521 | 16,091 | 12,881 | 18,734 | 23,091 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 21,950 | 17,476 | 21,210 | 23,085 | 25,116 | 20,487 | 27,347 | 33,298 |
| Operating Income (Loss) | (21,950) | (17,476) | (21,210) | (23,085) | (25,051) | (20,370) | (27,347) | (33,197) |
| Interest Income | 440.00 | 449.00 | 552.00 | 611.00 | 808.00 | 853.00 | 1,107 | 1,307 |
| Interest Expense | ||||||||
| Other Expense | (285.00) | (1.00) | (1,938) | (703.00) | 0.00 | (1,910) | (580.00) | 8.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (19,683) | 3,765 | (45,497) | (23,519) | (19,695) | (19,382) | (25,165) | (32,237) |
| Earnings Per Share (Basic) | (0.28) | 0.08 | (0.87) | (0.61) | (0.51) | (0.71) | (0.89) | (1.19) |
| Earnings Per Share (Diluted) | (0.28) | 0.08 | (0.87) | (0.61) | (0.51) | (0.71) | (0.89) | (1.19) |
| Weighted Average Shares Outstanding (Basic) | 69,102 | 46,886 | 52,169 | 38,830 | 38,614 | 27,161 | 28,140 | 27,198 |
| Weighted Average Shares Outstanding (Diluted) | 69,102 | 46,886 | 52,169 | 38,830 | 38,614 | 27,161 | 28,140 | 27,198 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About INO
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is a stock listed on the Nasdaq Stock Market under the ticker symbol INO. It last traded at $1.76 (Nov 20, 2026, 4:00 PM ET), up 2.9% on the day. That gives Inovio Pharmaceuticals a market capitalisation of $320.3M.
Over the past 52 weeks INO has traded between $0.5600 and $2.72.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $19.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $0 | -$19.7M |
| Dec 31, 2025 | $0 | $3.8M |
| Sep 30, 2025 | $0 | -$45.5M |
| Jun 30, 2025 | $0 | -$23.5M |
From Inovio Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…